Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Psychemedics Corp (NASDAQ:PMD)

23.80
Delayed Data
As of 3:04pm ET
 +0.85 / +3.68%
Today’s Change
13.00
Today|||52-Week Range
27.46
-3.59%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$125.3M

Company Description

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. Its testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company performs custom-designed enzyme immunoassay on the liquid supernatant, with confirmation testing by mass spectrometry. It provides screening and confirmation by mass spectrometry for cocaine; marijuana; phencyclidine; amphetamines including ecstasy; and opiates such as including heroin, hydrocodone, hydromorphone, oxycodone and codeine. Psychemedics was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Contact Information

Psychemedics Corp.
125 Nagog Park
Acton Massachusetts 01720
P:(877) 517-2033
Investor Relations:

Employees

Shareholders

Other institutional42.29%
Individual stakeholders18.76%
Mutual fund holders11.26%

Top Executives

Raymond C. KubackiChairman, President & Chief Executive Officer
Neil L. LernerTreasurer & Vice President-Finance
Michael I. SchafferVice President-Laboratory Operations
James V. DykeVice President-Sales & Marketing
Patrick J. KinneySecretary